Skip to main content

10x Genomics, Inc.

TXG
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001770787

In the last 90 days, 10x Genomics, Inc. insiders filed 0 open-market purchases and 11 sales; 393 institutions reported holding it in 13F filings for Q2 2026, worth $4.92B in total; superinvestors ARK Invest and Duquesne Family Office hold it.

Holders of 5% or more of TXG

Holders whose latest Schedule 13D or 13G filing reports 5% or more of 10x Genomics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TXG
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vanguard Group Inc13G/A11.60%13.3M shares–Oct 30, 20251 filingOct 30, 2025SEC
ARK Investment Management LLCSuperinvestorARK Invest13G/A10.39%11.9M shares−1.48 ppfrom 11.87%May 14, 20252 filingsNov 4, 2025SEC
FMR LLC13G/A8.10%9.28M shares−2.20 ppfrom 10.30%May 7, 20255 filingsNov 5, 2025SEC
BlackRock, Inc.13G/A7.60%8.50M shares–Jul 16, 20251 filingJul 16, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

17 Schedule 13D and 13G filings on 10x Genomics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TXG
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20259:02 AM ETNikko Asset Management Americas, Inc.13G/A4.70%5.38M shares−0.70 ppfrom 5.40%Below 5%Sep 30, 2025SEC
Nov 5, 202511:17 AM ETFMR LLCand 1 other13G/A8.10%9.28M shares−2.20 ppfrom 10.30%Sep 30, 2025SEC
Nov 4, 20254:43 PM ETARK Investment Management LLCand 1 otherSuperinvestorARK Invest13G/A10.39%11.9M shares−1.48 ppfrom 11.87%Sep 30, 2025SEC
Oct 30, 20252:04 PM ETVanguard Group Inc13G/A11.60%13.3M shares–Sep 30, 2025SEC
Oct 27, 20256:57 AM ETSumitomo Mitsui Trust Holdings, Inc.and 1 other13G/A4.70%5.38M shares−0.70 ppfrom 5.40%Below 5%Sep 30, 2025SEC
Aug 13, 20259:10 AM ETNikko Asset Management Americas, Inc.13G5.40%6.01M shares+0.40 ppfrom 5.00%Jun 30, 2025SEC
Aug 12, 20254:20 PM ETMillennium Management LLCand 2 others13G/A2.70%3.06M shares−2.40 ppfrom 5.10%Below 5%Jun 30, 2025SEC
Aug 7, 202510:06 AM ETFMR LLCand 1 other13G/A10.30%11.5M shares+1.50 ppfrom 8.80%Jul 31, 2025SEC
Aug 6, 202511:44 AM ETFMR LLCand 1 other13G/A8.80%9.84M shares+3.60 ppfrom 5.20%Jun 30, 2025SEC
Jul 31, 20256:07 AM ETSumitomo Mitsui Trust Holdings, Inc.and 1 other13G5.40%6.01M shares+0.40 ppfrom 5.00%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A7.60%8.50M shares–Jun 30, 2025SEC
May 14, 202510:50 AM ETARK Investment Management LLCand 1 otherSuperinvestorARK Invest13G/A11.87%12.8M shares–Mar 31, 2025SEC
May 12, 20251:58 PM ETNikko Asset Management Americas, Inc.13G/A5.00%5.36M shares–Mar 31, 2025SEC
May 7, 202510:55 AM ETFMR LLCand 1 other13G/A5.20%5.65M shares−7.80 ppfrom 13.00%Apr 30, 2025SEC
May 7, 202510:40 AM ETFMR LLCand 1 other13G/A13.00%14.7M shares–Mar 31, 2025SEC
Apr 25, 20256:22 AM ETSumitomo Mitsui Trust Holdings, Inc.and 1 other13G/A5.00%5.36M shares–Mar 31, 2025SEC
Apr 4, 20254:00 PM ETMillennium Management LLCand 2 others13G5.10%5.53M sharesNewApr 1, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell 10x Genomics, Inc. shares.

No Form 144 notices for 10x Genomics, Inc. are on file.